Biblio

Author Title [ Type

] Year

Filters: Author is Kim, Sung-Hak [Clear All Filters]

Journal Article

Otvos B, Silver DJ, Mulkearns-Hubert EE, Alvarado AG, Turaga SM, Sorensen MD, Rayman P, Flavahan WA, Hale JS, Stoltz K, et al. Cancer stem cell-secreted macrophage migration inhibitory factor stimulates myeloid derived suppressor cell function and facilitates glioblastoma immune evasion. Stem Cells. 2016.

Kim H-J, Jeon H-M, Batara DCarlo, Lee S, Lee SJun, Yin J, Park S-I, Park M, Seo JBae, Hwang J, et al. CREB5 promotes the proliferation and self-renewal ability of glioma stem cells. Cell Death Discov. 2024;10(1):103.

Kim H-J, Batara DCarlo, Jeon Y-J, Lee S, Beck S, Kim S-H. The impact of TALE homeodomain transcription factor knockdown on glioma stem cell growth. Anim Cells Syst (Seoul). 2024;28(1):93-109.

Zhou S, Niu R, Sun H, Kim S-H, Jin X, Yin J. The MAP3K1/c-JUN signaling axis regulates glioblastoma stem cell invasion and tumor progression. Biochem Biophys Res Commun. 2022;612:188-195.

Mao P, Joshi K, Li J, Kim S-H, Li P, Santana-Santos L, Luthra S, Chandran UR, Benos PV, Smith L, et al. Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3. Proc Natl Acad Sci U S A. 2013.

Gallego-Perez D, Chang L, Shi J, Ma J, Kim S-H, Zhao X, Malkoc V, Wang X, Minata M, Kwak KJoo, et al. On-chip clonal analysis of glioma stem cell motility and therapy resistance. Nano Lett. 2016.

Minata M, Audia A, Shi J, Lu S, Bernstock J, Pavlyukov MS, Das A, Kim S-H, Shin YJae, Lee Y, et al. Phenotypic Plasticity of Invasive Edge Glioma Stem-like Cells in Response to Ionizing Radiation. Cell Rep. 2019;26(7):1893-1905.e7.

Kim S-H, Ezhilarasan R, Phillips E, Gallego-Perez D, Sparks A, Taylor D, Ladner K, Furuta T, Sabit H, Chhipa R, et al. Serine/Threonine Kinase MLK4 Determines Mesenchymal Identity in Glioma Stem Cells in an NF-κB-dependent Manner. Cancer Cell. 2016;29(2):201-213.

Yamashita D, Bernstock JD, Elsayed G, Sadahiro H, Mohyeldin A, Chagoya G, Ilyas A, Mooney J, Estevez-Ordonez D, Yamaguchi S, et al. Targeting glioma-initiating cells via the tyrosine metabolic pathway. J Neurosurg. 2020:1-12.

Batara DCarlo, Park SWook, Kim H-J, Choi S-Y, Ohn T, Choi M-C, Park S-I, Kim S-H. Targeting the multidrug and toxin extrusion 1 gene (SLC47A1) sensitizes glioma stem cells to temozolomide. Am J Cancer Res. 2023;13(9):4021-4038.